This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Immunocellular Therapeutics, Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Manish Singh: Innovator in Immunogen Research
Introduction
Manish Singh is a notable inventor based in Woodland Hills, CA. He has made significant contributions to the field of immunogen research, holding two patents that showcase his innovative work. His expertise and dedication to advancing medical science have positioned him as a key figure in his industry.
Latest Patents
Manish Singh's latest patents focus on CD133 epitopes. The first patent describes an immunogen that includes an isolated peptide with the amino sequence of any one of SEQ ID NOs:1-21, allowing for four or fewer amino acid substitutions. The second patent is similar, emphasizing the importance of these epitopes in immunogen development.
Career Highlights
Manish Singh is currently associated with ImmunoCellular Therapeutics, Ltd., where he applies his knowledge and skills to further research and development in immunotherapy. His work has been instrumental in exploring new avenues for treatment and understanding of various diseases.
Collaborations
Manish collaborates with several professionals in his field, including his coworker James Bender. Their combined efforts contribute to the advancement of innovative solutions in immunogen research.
Conclusion
Manish Singh's contributions to immunogen research through his patents and work at ImmunoCellular Therapeutics, Ltd. highlight his role as an influential inventor in the medical field. His ongoing research continues to pave the way for future advancements in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile